Skip to content
★ Sign in to follow
KS

Kenneth Song

CEO
RayzeBio, Inc.Freenome, Inc.
Total declarations
2
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 24 Jul 2026 for Freenome, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Kenneth Song: trading record in brief

Kenneth Song has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Freenome, Inc. and RayzeBio, Inc. We count 2 filings; the first trade dates from 26 February 2024 and the latest from 20 July 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

The latest filing, published on 24 July 2026, reports a transaction in Freenome, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Kenneth Song

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    ExecutivesFreenome, Inc.
    0SEC
    30,000 sharesCommon StockSEC:0001602787-26-000004:0
  • ●
    PRESIDENT AND CHIEF EXECUTIVEExecutivesRayzeBio, Inc.
    101M USD30SEC
    1,622,968 shares@ US$62.50100.0% of flowCommon StockSEC:0001415889-24-005500:0

2 of 2 declarations